Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy
You Ke,1 Cheng Xiang2 1Department of Nephrology, The Second Affiliated Hospital of Zhejiang University, Hangzhou, China; 2Department of Surgery, The Second Affiliated Hospital of Zhejiang University, Hangzhou, China Background: Thyroid cancer becomes the most common endocrine cancer with the great...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/982fc76b45f340d6a995fcae8a006fdd |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|